KBC Group’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $501K | Sell |
3,760
-12,906
| -77% | -$2.05M | ﹤0.01% | 785 |
|
|
2025
Q4 | $2.89M | Buy |
16,666
+7,681
| +85% | +$1.26M | 0.01% | 549 |
|
|
2025
Q3 | $1.72M | Sell |
8,985
-76,365
| -89% | -$14.1M | ﹤0.01% | 618 |
|
|
2025
Q2 | $25.4M | Sell |
85,350
-40,871
| -32% | -$12.8M | 0.07% | 246 |
|
|
2025
Q1 | $41.6M | Buy |
126,221
+735
| +0.6% | +$222K | 0.13% | 172 |
|
|
2024
Q4 | $36.5M | Buy |
125,486
+15,993
| +15% | +$4.94M | 0.1% | 202 |
|
|
2024
Q3 | $37.7M | Sell |
109,493
-67,685
| -38% | -$22.3M | 0.11% | 176 |
|
|
2024
Q2 | $52.7M | Buy |
177,178
+166,030
| +1,489% | +$56.4M | 0.16% | 121 |
|
|
2024
Q1 | $4.58M | Sell |
11,148
-5,317
| -32% | -$2.06M | 0.01% | 462 |
|
|
2023
Q4 | $5.95M | Sell |
16,465
-40,083
| -71% | -$14.1M | 0.02% | 437 |
|
|
2023
Q3 | $18.5M | Sell |
56,548
-49,334
| -47% | -$15.5M | 0.08% | 247 |
|
|
2023
Q2 | $31.9M | Buy |
105,882
+85,080
| +409% | +$24.5M | 0.13% | 158 |
|
|
2023
Q1 | $5.57M | Buy |
20,802
+7,686
| +59% | +$2.21M | 0.02% | 461 |
|
|
2022
Q4 | $4.33M | Buy |
13,116
+6,708
| +105% | +$2.28M | 0.02% | 452 |
|
|
2022
Q3 | $2.11M | Buy |
6,408
+7
| +0.1% | +$2.25K | 0.01% | 538 |
|
|
2022
Q2 | $1.79M | Buy |
6,401
+132
| +2% | +$39.9K | 0.01% | 562 |
|
|
2022
Q1 | $2.09M | Buy |
6,269
+439
| +8% | +$135K | 0.01% | 578 |
|
|
2021
Q4 | $1.85M | Sell |
5,830
-3,962
| -40% | -$1.18M | 0.01% | 618 |
|
|
2021
Q3 | $2.66M | Sell |
9,792
-9,792
| -50% | -$2.59M | 0.01% | 608 |
|
|
2021
Q2 | $4.96M | Hold |
19,584
| – | – | 0.01% | 623 |
|
|
2021
Q1 | $4.58M | Buy |
19,584
+102
| +0.5% | +$22.7K | 0.01% | 625 |
|
|
2020
Q4 | $22.8M | Sell |
19,482
-135,450
| -87% | -$28M | 0.01% | 635 |
|
|
2020
Q3 | $28.4M | Buy |
154,932
+82,714
| +115% | +$15M | 0.08% | 231 |
|
|
2020
Q2 | $12.9M | Buy |
72,218
+24,531
| +51% | +$4.18M | 0.04% | 348 |
|
|
2020
Q1 | $6.66M | Sell |
47,687
-14,940
| -24% | -$2M | 0.06% | 316 |
|
|
2019
Q4 | $8.5M | Buy |
62,627
+36,962
| +144% | +$4.66M | 0.05% | 351 |
|
|
2019
Q3 | $2.82M | Buy |
+25,665
| New | +$3.32M | 0.02% | 549 |
|
|
2016
Q4 | – | Sell |
-1,806
| Closed | -$105K | – | 1320 |
|
|
2016
Q3 | $105K | Hold |
1,806
| – | – | ﹤0.01% | 1223 |
|
|
2016
Q2 | $90K | Buy |
+1,806
| New | +$96.5K | ﹤0.01% | 1173 |
|
|
2015
Q3 | – | Sell |
-72,393
| Closed | -$5.09M | – | 1362 |
|
|
2015
Q2 | $5.09M | Buy |
72,393
+67,146
| +1,280% | +$4.49M | 0.07% | 331 |
|
|
2015
Q1 | $353K | Hold |
5,247
| – | – | ﹤0.01% | 985 |
|
|
2014
Q4 | $281K | Sell |
5,247
-5,106
| -49% | -$247K | ﹤0.01% | 1115 |
|
|
2014
Q3 | $438K | Sell |
10,353
-6,128
| -37% | -$271K | 0.02% | 785 |
|
|
2014
Q2 | $736K | Hold |
16,481
| – | – | 0.01% | 820 |
|
|
2014
Q1 | $619K | Hold |
16,481
| – | – | 0.01% | 778 |
|
|
2013
Q4 | $573K | Buy |
16,481
+13,058
| +381% | +$440K | 0.01% | 808 |
|
|
2013
Q3 | $122K | Buy |
+3,423
| New | +$126K | ﹤0.01% | 1062 |
|
Other funds holding MOH
VPM
VCM
KBC Group's MOH Position: Q1 2026 in Review
KBC Group reduced its Molina Healthcare (MOH) stake by 77% in Q1 2026, selling an estimated $2.05M and leaving 3,760 shares worth $501K. The position accounts for ﹤0.01% of the portfolio, ranked #785.
KBC Group first reported a position in MOH in Q3 2013 and has held it in 37 quarters since. The position peaked at $52.7M in Q2 2024. 524 funds tracked by Wall St. Rank hold MOH as of Q1 2026.
- KBC Group held 3,760 shares of Molina Healthcare worth $501K as of Q1 2026.
- KBC Group sold 12,906 Molina Healthcare shares in Q1 2026, an estimated $2.05M.
- Molina Healthcare made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #785 holding.
- KBC Group first reported a position in Molina Healthcare in Q3 2013 and has held it in 37 quarters since.
- KBC Group's Molina Healthcare position peaked at $52.7M in Q2 2024.
- 524 funds tracked by Wall St. Rank held Molina Healthcare as of Q1 2026.
Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.